Organon & Co | OGN - Devedores Comerciais





Devedores Comerciais Alterar Data
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Celltrion KRW 2.01T 39.71B 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Merck USD 11.78B 345M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Organigram Holdings CAD 53.39M 3.45M 2026-03
Organon & Co USD 1.38B 53M 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pharma Mar EUR 51.19M 9.4M 2026-03
Qiagen NV USD 402.61M 9.05M 2025-12
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12